Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
RK is recorded as Analyst at H.C. Wainwright. RK has spoken on 4 earnings calls across 4 companies, most recently for Eton Pharmaceuticals, Inc. on August 13, 2026. Those appearances were for Eton Pharmaceuticals, Inc. (ETON), MediWound Ltd. (MDWD), Corcept Therapeutics Inc (CORT) and Aethlon Medical Inc (AEMD). The companies whose calls RK spoke on are classified in the Healthcare sector.
“I know a lot of my questions have been asked. In general, it's just trying to understand how you plan on having ASM001 and Hemangiol work out that franchise, especially with Hemangiol patent running out in October 28, I believe.”
“So just thinking through the program with SCRx, beyond the current study, just trying to have an idea of how the additional studies which you are planning, especially on the indication expansion, the DFU, and the IIT on pressure ulcer.”
“With the cohort two, you know, two out of three patients, and, you know, if I understood it correctly, you are basically using the same patients who had, who were in cohort one into the cohort two.”
H.C. Wainwright
Analyst
Source not stated
Drug Manufacturers - Specialty & Generic · Healthcare
MDWD
Biotechnology · Healthcare
AEMD
Medical Devices · Healthcare
